Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation
Xiaoxiao Guo, Zhenhu Guo, Jingsong Lu, et al.
Nanoscale (2021) Vol. 13, Iss. 34, pp. 14525-14537
Closed Access | Times Cited: 10

Showing 10 citing articles:

Immunogenic Radiation Therapy for Enhanced Antitumor Immunity via a Core–Shell Nanosensitizer-Mediated Immunosuppressive Tumor Microenvironment Modulation
Nai-Han Huang, Xiao‐Yan Tang, Wei Meng, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 19853-19864
Closed Access | Times Cited: 19
Novel strategies for tumor radiosensitization mediated by multifunctional gold-based nanomaterials
Ze Wang, Xiaojun Ren, Dongzhou Wang, et al.
Biomaterials Science (2022) Vol. 11, Iss. 4, pp. 1116-1136
Closed Access | Times Cited: 24
Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment
Nolan Jackson, Daniel Cecchi, Wayne Beckham, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2438-2438
Open Access | Times Cited: 6
Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics
Nolan Jackson, Iona Hill, Abdulaziz Alhussan, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy
Liam Widjaja, Rudolf A. Werner, Elke Krischke, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 2, pp. 602-612
Open Access | Times Cited: 17
ATM is associated with the prognosis of colorectal cancer: a systematic review
Pei Wu, Ze‐Lin Wen
Frontiers in Oncology (2025) Vol. 15
Open Access
Size-changeable nanoprobes for the combined radiotherapy and photodynamic therapy of tumor
Zhenyu Hou, Mei Zhou, Yuanyuan Ma, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2655-2667
Closed Access | Times Cited: 15
Immunogenic radiation therapy for enhanced anti-tumor immunity via core-shell nanocomposite-mediated multiple strategies
Nai-Han Huang, Along Qian, Yi‐Ming Zou, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4121-4137
Open Access | Times Cited: 8
Nanomedicine for urologic cancers: diagnosis and management
Chunyang Li, Xiaoxi Zeng, Shi Qiu, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 463-475
Closed Access | Times Cited: 10
pH-triggered “PEG” sheddable and folic acid-targeted nanoparticles for docetaxel delivery in breast cancer treatment
F. F. Sui, Zengjun Fang, Lingjun Li, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123293-123293
Closed Access | Times Cited: 5
Page 1

Scroll to top